Advertisement

Topics

Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27

17:01 EST 12 Nov 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Webcast Available Through Gilead Corporate Website Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer, and John McHutchison, AO, MD,...

Other Sources for this Article

Gilead Sciences, Inc.
Sung Lee, 650-524-7792
Investor Relations

NEXT ARTICLE

More From BioPortfolio on "Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...